Polypharmacy and bone fracture risk in patients with type 2 diabetes: the Fukuoka Diabetes Registry

Along with worldwide population aging, diabetes mellitus and its complications have become important public health issues that are associated with increases in mortality, morbidity, and healthcare costs [1]. Multiple studies have shown that men and women with diabetes have an increased risk of fracture at any anatomical site [2], resulting in the consensus that osteoporosis and its related bone fractures comprise a complication of diabetes [3]. Fractures, especially fragility fractures, decrease the patient ’s quality of life, increase healthcare costs, and increase the mortality risk in patients with diabetes [3,4].

Source: Diabetes Research and Clinical Practice - October 19, 2021 Category: Endocrinology Authors: Yuji Komorita, Toshiaki Ohkuma, Masanori Iwase, Hiroki Fujii, Yutaro Oku, Taiki Higashi, Ayaka Oshiro, Wakako Sakamoto, Masahito Yoshinari, Udai Nakamura, Takanari Kitazono Source Type: research